Ulcers in Biological Technology
Navigation Links
Ulcers in Biological Technology
...
Chronic ulcerations such as diabetic foot ulcers are often colonized or contaminated with bacterial pathogens that can prevent ulcers from healing. A high proportion of such wounds ... of bacterial resistance. Furthermore, diabetic ulcers are often associated with vascular disease and ...
... the prevalence and prevention of NSAID-induced ulcers available at www.connecttoprotect.com - ... and their patients, NSAID-associated GI ulcers are rarely discussed, and when they are it is ... the stomach are reduced, NSAIDs often cause ulcers in the stomach. It is estimated that GI ...
... and patients globally. Diabetic foot ulcers are painful, open sores that develop on the feet ... not diagnosed and treated promptly, diabetic foot ulcers can cause extensive damage to soft-tissue and ... risk for developing a foot ulcer; half of these ulcers become infected. Of these, 1 in 4 will undergo ...
... appeared less likely to heal rapidly, as did ulcers that that were mechanically debrided. -- A ... on healing rates of 71 non-healing venous leg ulcers showed that none of the patients receiving ... under compression devices -- saw the ulcers heal completely during the duration of the ...
... Over 1 million patients with non-healing leg ulcers each year in the US PRINCETON, N.J., March 20 ... are over 1 million patients with non-healing leg ulcers each year in the US. That number is growing along ... at the APWCA, CEO Edward Quilty said, "Venous leg ulcers can be some of the most difficult to manage. ...
... of Tissue Repair's Gene Activated Matrix(TM) or GAM(TM) technology for ulcers and other potential applications, including not only the repair of soft ... the use of Excellarate for the potential treatment of diabetic foot ulcers and other potential GAM product candidates is expected to be reported over ...
... from a managed care population over the course of eight years. The study authors concluded that the most notable serious conditions were decubitus ulcers (bed sores, 5-fold higher), seizures (4-fold higher), hip fractures, (3-fold higher), depression (3-fold higher), and pneumonia (2-fold higher). ...
... to medical collaboration in the Middle East, which continues to have unfortunate repercussions. Additionally, research thrusts aimed at diabetic skin ulcers have met unusual resistance. And, recently, Ozonics experienced a setback in a U.S.- Australian endeavor using Ozonics' proprietary technology ...
... 2b MATRIX clinical trial to evaluate the safety and efficacy of its Excellarate product candidate for the potential treatment of non-healing foot ulcers in patients with type I or type II diabetes. In addition, on May 7, 2009, Cardium announced significant new formulation enhancements for Excellarate ...
... anticipates initiating human clinical trials for topical use of its Nu-3 NuBiotics(R) compound in the near future for indications including; diabetic ulcers and other topical infections. Future studies will involve the use of Nu-2(R) to treat broad spectrum antibiotic-resistant bacterial pulmonary and ...
... infections involving the deeper soft tissue, including severe cellulitis and major abscesses. These infections may occur in patients with skin ulcers or burns, as well as patients who have undergone surgery or experienced other kinds of trauma. These infections affect over one million patients in ...
... The MATRIX Phase 2b clinical trial is evaluating the safety and efficacy of Excellarate for the potential treatment of non-healing diabetic foot ulcers and is expected to enroll up to approximately 210 patients at up to 30 U.S. sites. The Company expects to provide selected top-line data from the ...
... for GLYC-101. The strategic priorities for GLYC-101 include wound healing following laser ablation, burn wounds, surgical wounds, venous ulcers and diabetic ulcers. About Glycotex, Inc. Glycotex, Inc. is a U.S. based development stage biopharmaceutical company focused on discovering and ...
... Americans and is a significant cause of both morbidity and death. Patients with PAD may experience muscle pain during walking, have wounds and ulcers that are slow to heal or, in the most severe cases, require amputation of the legs. Current interventional procedures, such as balloon angioplasty, ...
... the prevalence and prevention of NSAID-induced ulcers available at www.connecttoprotect.com - ... and their patients, NSAID-associated GI ulcers are rarely discussed, and when they are it is ... the stomach are reduced, NSAIDs often cause ulcers in the stomach. It is estimated that GI ...
... and patients globally. Diabetic foot ulcers are painful, open sores that develop on the feet ... not diagnosed and treated promptly, diabetic foot ulcers can cause extensive damage to soft-tissue and ... risk for developing a foot ulcer; half of these ulcers become infected. Of these, 1 in 4 will undergo ...
Wound Management Technologies, Inc. Announces a Published Case Study
... ulcer in their lifetime and that 14-24% of these ulcers will result in amputations. Every 30 seconds a ... to: diabetic ulcers, venous stasis ulcers, ulcers due to arterial insufficiency, pressure ulcers stages I-IV, surgical wounds, traumatic wounds, ...International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
... to care for patients who have acquired pressure ulcers while under hospital care. This is one component ... pressure ulcer prevention and care. Pressure ulcers are an enormous concern to the healthcare ... reported 257,412 cases of preventable pressure ulcers as a secondary diagnosis. The average cost per ...... appeared less likely to heal rapidly, as did ulcers that that were mechanically debrided. -- A ... on healing rates of 71 non-healing venous leg ulcers showed that none of the patients receiving ... under compression devices -- saw the ulcers heal completely during the duration of the ...
... Over 1 million patients with non-healing leg ulcers each year in the US PRINCETON, N.J., March 20 ... are over 1 million patients with non-healing leg ulcers each year in the US. That number is growing along ... at the APWCA, CEO Edward Quilty said, "Venous leg ulcers can be some of the most difficult to manage. ...
Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers
... of thousands of patients with diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) in the U.S. ... and others prone to chronic venous leg ulcers and diabetic foot ulcers. The campaign will ... CA. "Additionally, unhealed diabetic foot ulcers can result in infection, hospitalization and ...Innocoll Announces Closing of $30 Million Equity Financing Investment
... and prevention of infected diabetic foot ulcers and CollaRx BUPIVACAINE IMPLANT for the ... of bacterial resistance. Furthermore, diabetic ulcers are often associated with vascular disease and ... infected, mildly infected and uninfected ulcers in a parallel series of three phase 2 ...Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
... the prevention and treatment of pressure ulcers to enhance patient safety and comfort ... for comfort. "Our goal is to prevent pressure ulcers and to create a safe environment," said Janice ... microclimate and comfort." Avoiding pressure ulcers has assumed greater importance for ...... of Tissue Repair's Gene Activated Matrix(TM) or GAM(TM) technology for ulcers and other potential applications, including not only the repair of soft ... the use of Excellarate for the potential treatment of diabetic foot ulcers and other potential GAM product candidates is expected to be reported over ...
Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge
... wounds including: diabetic ulcers, venous ulcers, pressure ulcers, ulcers caused by mixed vascular etiologies, full-thickness & partial ... Topical for the treatment and prevention of infected diabetic foot ulcers and CollaRx Bupivacaine Implant for the management of post-operative pain, ...Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb
... hospitalizations are estimated at over $2.5 billion. Failure of these ulcers to heal often leads to lower extremity amputation (LEA). In addition, ... years. The estimated annual cost of care for treatment of lower extremity ulcers is roughly $130,000 per patient. This cost includes physician visits, ...EnzySurge, Maker of DermaStream(TM), Completes Funding Round of US$4 Million
... to treat all forms of chronic wounds including diabetic ulcers, venous ulcers and pressure ulcers. DermaStream touch-free treatments result in faster, ... of a multi-centered, double blind clinical trial focused on chronic leg ulcers (venous ulcers). The intermediate results of the trial indicate a ...Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
... is used by doctors successfully in treating patients with diabetic foot ulcers and venous leg ulcers in the U.S. and other markets across the world. In addition to acquiring ...Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants
... skin cooling as a method to prevent tissue damage caused by pressure ulcers -- formed by the pressure on skin that is constantly bearing force from ... cushions with cooling capacity for the prevention of pressure ulcers for people in the paralysis community. Each research application ...Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008
... particularly targeting wounds that are difficult to heal, such as pressure ulcers (bedsores), venous ulcers and diabetic leg ulcers, conditions that are becoming more common as the ...UCLA welcomes startup to new incubator space at California NanoSystems Institute
... that benefits from UCLA's great resources. "We hope that this technology will help to reduce the large number of injuries caused by diabetic foot ulcers and by falls each year, both in hospital rehabilitation departments and in at-home care environments," Sarrafzadeh said. "We anticipate great ...Exciton Technologies receives FDA approval to market exSALT(TM)
... Wound Dressing targets the advanced wound care market in preventing infection during the treatment of burn and chronic wounds such as diabetic foot ulcers and bed sores. By adjusting the dose of silver and expanding the number of product configurations, Exciton can target a greater portion of the ...... from a managed care population over the course of eight years. The study authors concluded that the most notable serious conditions were decubitus ulcers (bed sores, 5-fold higher), seizures (4-fold higher), hip fractures, (3-fold higher), depression (3-fold higher), and pneumonia (2-fold higher). ...
Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer
... dose of the most potent H2 antagonist, famotidine. HZT-501 was shown to significantly reduce the incidence of NSAID-induced upper gastrointestinal ulcers in patients with mild-to-moderate pain in two Phase 3 studies. Dr. Sherman joins Horizon from IDM Pharma, which was recently purchased by Takeda ...Video: Varicose Veins, Much More Than a Cosmetic Issue, Can Prove a Health Risk
... restlessness and throbbing. Varicose veins may enlarge and worsen over time and, if untreated, could lead to serious complications, such as leg ulcers or blood clots. There are many factors that can increase a person's chances of developing varicose veins, including heredity, age, gender, and ...... to medical collaboration in the Middle East, which continues to have unfortunate repercussions. Additionally, research thrusts aimed at diabetic skin ulcers have met unusual resistance. And, recently, Ozonics experienced a setback in a U.S.- Australian endeavor using Ozonics' proprietary technology ...
... 2b MATRIX clinical trial to evaluate the safety and efficacy of its Excellarate product candidate for the potential treatment of non-healing foot ulcers in patients with type I or type II diabetes. In addition, on May 7, 2009, Cardium announced significant new formulation enhancements for Excellarate ...
... anticipates initiating human clinical trials for topical use of its Nu-3 NuBiotics(R) compound in the near future for indications including; diabetic ulcers and other topical infections. Future studies will involve the use of Nu-2(R) to treat broad spectrum antibiotic-resistant bacterial pulmonary and ...
Sinobiomed Announces New Executive Team
... products respond to a wide range of diseases and conditions, including: malaria, hepatitis, surgical bleeding, cancer, rheumatoid arthritis, diabetic ulcers and burns, and blood cell regeneration. FORWARD LOOKING STATEMENTS This news release may include "forward-looking statements" regarding ...... infections involving the deeper soft tissue, including severe cellulitis and major abscesses. These infections may occur in patients with skin ulcers or burns, as well as patients who have undergone surgery or experienced other kinds of trauma. These infections affect over one million patients in ...
Horizon Therapeutics Announces Senior Management Appointments
... with ibuprofen alone. In REDUCE-2, 24-week treatment with HZT-501 resulted in a statistically significant reduction in gastric and/or duodenal ulcers versus treatment with ibuprofen alone. The trials were conducted via a Special Protocol Assessment (SPA) with the U.S. Food and Drug ...... The MATRIX Phase 2b clinical trial is evaluating the safety and efficacy of Excellarate for the potential treatment of non-healing diabetic foot ulcers and is expected to enroll up to approximately 210 patients at up to 30 U.S. sites. The Company expects to provide selected top-line data from the ...
Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
... sensations and pain particularly in the toes or feet. This gradually evolves to loss of sensation and motor function as nerve damage progresses. ulcers and sores may appear on numb areas of the foot because pressure or injury goes unnoticed. Despite adequate treatment, these areas of trauma ...... for GLYC-101. The strategic priorities for GLYC-101 include wound healing following laser ablation, burn wounds, surgical wounds, venous ulcers and diabetic ulcers. About Glycotex, Inc. Glycotex, Inc. is a U.S. based development stage biopharmaceutical company focused on discovering and ...
... Americans and is a significant cause of both morbidity and death. Patients with PAD may experience muscle pain during walking, have wounds and ulcers that are slow to heal or, in the most severe cases, require amputation of the legs. Current interventional procedures, such as balloon angioplasty, ...
Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
... products respond to a wide range of diseases and conditions, including: malaria, hepatitis, surgical bleeding, cancer, rheumatoid arthritis, diabetic ulcers and burns, and blood cell regeneration. http://www.sinobiomed.com FORWARD LOOKING STATEMENTS This news release may include "forward-looking ...Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States
... products in Innocoll's development pipeline include CollaRx Gentamicin Topical for the treatment and prevention of infected diabetic foot ulcers and CollaRx Bupivacaine Implant for the management of post-operative pain, both of which are currently in Phase II development. For more information, ...Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors
... products in Innocoll's development pipeline include CollaRx Gentamicin Topical for the treatment and prevention of infected diabetic foot ulcers and CollaRx Bupivacaine Implant for the management of post-operative pain, both of which are currently in Phase 2 development. For more information, ...EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board
... regeneration to closure. The DermaStream family of products is designed to treat all forms of chronic wounds including diabetic ulcers, venous ulcers and pressure ulcers. DermaStream touch-free treatments result in faster, more effective and painless wound healing in the hospital, clinics, nursing ...Immunosyn Corporation Files 10-Q
... the potential to affect a number of clinical conditions including complications from Diabetic Mellitus such as Diabetic Neuropathy (DN) and diabetic ulcers (DU), auto-immune disorders such as Multiple Sclerosis (MS) and neurological disorders such as Chronic Inflammatory Demyelinating Polyneuropathy ...Cardium Reports on First Quarter 2008 Highlights and Financial Results
... . The MATRIX clinical trial is evaluating the safety and efficacy of Excellarate for the potential treatment of non-healing diabetic foot ulcers and is expected to enroll approximately 210 patients at up to 40 U.S. sites. Additional information about the MATRIX study can be found at ...Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R)
... market." Dermagraft is a bioengineered tissue product approved by the Food and Drug Administration (FDA) for the treatment of diabetic foot ulcers (DFUs). DFUs, a complication of diabetes, affect more than 400,000 people every year in the US. If not treated properly, DFUs can result in ...Maryland Approves Medicaid Reimbursement for ActiPatch(R)
... Motrin, Nuprin) and Naproxen (Aleve, Anaprox, Naprosyn) with regular use and most especially long-term use, can have serious complications such as ulcers and bleeding from the gastrointestinal tract. These medications have been known to worsen cardiovascular conditions, increase high blood pressure, ...Other ContentsgoosechartschartschartschartsgrandgrandgrandgrandversusversusversusversusversusversusversusversusversusgoutgoutinguinalegrassgrassgrassgrassgrassOther TagsInhalerPrevalentPerceptionPerceptionTeacherLovedProtected
(Date:11/25/2009)...BER 25, 2009 Soil is the linchpin of the environm...meet. Despite that, many students see soil as "jus... Soil science educators are challenged with the ta...e critical importance of soil in the environment. ...arth science teachers at University of Nebraska-Li...
(Date:11/25/2009)...versity assistant professors recently received fun... continue research beneficial to understanding the... Christopher Blackwood, assistant professor in the...ants to support two separate research projects. ,...omposer Communities and Functions from the Leaf to...
(Date:11/24/2009)...ears it has been prescribed by traditional healers...ches and stomach pain to fever and flu. , Now for...ty have been able to scientifically prove the pain...se known as Brazilian mint. , Testing this ancien...earcher Graciela Rocha was able to show that when ...
Breaking Biology News(10 mins):It's not just dirt! 2Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2October 2009 Mayo Clinic Womens HealthSource Highlights Ductal Carcinoma In Situ New Hearing Aid Options and Self Acceptance 60013 1October 2009 Mayo Clinic Womens HealthSource Highlights Ductal Carcinoma In Situ New Hearing Aid Options and Self Acceptance 60013 2October 2009 Mayo Clinic Womens HealthSource Highlights Ductal Carcinoma In Situ New Hearing Aid Options and Self Acceptance 60013 3October 2009 Mayo Clinic Womens HealthSource Highlights Ductal Carcinoma In Situ New Hearing Aid Options and Self Acceptance 60013 4October 2009 Mayo Clinic Womens HealthSource Highlights Ductal Carcinoma In Situ New Hearing Aid Options and Self Acceptance 60013 5FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir for 2009 H1N1 Influenza for Certain Patients Settings 60010 1FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir for 2009 H1N1 Influenza for Certain Patients Settings 60010 2Dr Siegals Cookie Diet Book Cracks the Amazon Top 500 60007 1Dr Siegals Cookie Diet Book Cracks the Amazon Top 500 60007 2Dr Siegals Cookie Diet Book Cracks the Amazon Top 500 60007 3Dr Siegals Cookie Diet Book Cracks the Amazon Top 500 60007 4(Date:11/30/2009)..., , MINNEAPOLIS, Nov. 30 /PRNewswire...Shock Doctor , is now required equipment in the To...orcycle classes of the National Hot Rod Associatio... as for Top Alcohol dragster and Top Alcohol Funny...ies. Eject is the only product that allows medic...
(Date:11/30/2009)... Keynote speaker & Aut...sm , Corpus Christi, TX ...as Autism Conference is set to be held in Corpus ..., December 5, 2009 at the American Bank Center., ,...nd is expected to make a nearly $300,000 economic ...
(Date:11/30/2009)..., , SHORT HILLS, N.J., Nov. 30 /PRNewswire/ ...th Technologies, Inc. and OmniActive Health Techno...le settlement of their dispute. The parties agree ...tent") titled "Process for Isolation, Purification...arigold Oleoresin and Uses Thereof" and the reissu...
(Date:11/30/2009)..., , BRIDGEWATER, N.J., Nov. 30 /PRNewswire/...U.S. provider of meeting logistics, speaker progra...or the life sciences industry, announced it has be... state by NJBIZ, New Jersey,s leading statewide bu...op fifty businesses that have made significant con...
(Date:11/30/2009)... CHICAGONovember 30, 2009A pet owner knows the eno...especially in troubled times. Most pets are consid...able companions. A growing body of research now do...d development, elderly care, mental illness, physi...y, and the rehabilitation of incarcerated youth an...
Breaking Medicine News(10 mins):Health News:National Hot Rod Association Mandates Eject Helmet Removal System for 2010 2Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2Health News:Advanced Health Media Honored at NJ Finest Award Ceremony 2Health News:The therapeutic benefits of the human-animal bond 2[0] National Hot Rod Association Mandates Eject Helmet Removal System for 2010[0] 18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact[0] OmniActive and Kemin Reach Amicable Settlement in Patent Dispute[0] Advanced Health Media Honored at NJ Finest Award Ceremony[0] The therapeutic benefits of the human-animal bond
DemonstrationsRussellSeroxatPrecautiousInhalerAppalachiansEducationistsPrevalentStalkingStagnantPerceptionTeacherLovedProtected
Other Tagsprecancerous 2elucidate 2transporter 2downstream 2downstream 3fire 2fire 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |